Interferon-free therapy of hepatitis C during wait list and post-transplant risk of hepatocellular carcinoma recurrence

J Hepatol. 2017 Dec;67(6):1355-1356. doi: 10.1016/j.jhep.2017.07.026. Epub 2017 Aug 10.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antiviral Agents*
  • Carcinoma, Hepatocellular*
  • Hepatitis C*
  • Humans
  • Liver Neoplasms*
  • Liver Transplantation*
  • Neoplasm Recurrence, Local

Substances

  • Antiviral Agents